Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1-positive non-small cell lung cancer

相似書籍

• Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib
  由: Chen, Hua-fei, et al.
  出版: (2018)
• Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review
  由: Zhu, You‐cai, et al.
  出版: (2017)
• The clinicopathological and prognostic features of Chinese and Japanese inpatients with lung cancer
  由: Gao, Yang, et al.
  出版: (2016)
• Efficacy of crizotinib and pemetrexed-based chemotherapy in Chinese NSCLC patients with ROS1 rearrangement
  由: Zhang, Limin, et al.
  出版: (2016)
• A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib
  由: Zhu, You-cai, et al.
  出版: (2018)